Morsch, André Luis Bittencourt;
Henrique, Lilian Rodrigues;
Silva, Denise Rossato;
Garziera, Giovana;
Xavier, Ricardo Machado;
Hax, Vanessa;
Ferreira, Manoela Fantinel;
Kohem, Charles Lubianca;
Mancuso, Aline Castello Branco;
Gasparin, Andrese Aline;
Brenol, Claiton Viegas;
Andrade, Nicole Pamplona Bueno de;
Menegat, Franciele de Almeida;
Viecceli, Daniela;
Bohn, Renata;
Palominos, Penélope Esther.
Introduction: Registries of spondyloarthritis (SpA) patients’ follow-up provided evidence that tumor necrosis factor inhibitors (TNFi) increase the incidence of active tuberculosis infection (TB). However, most of these registries are from low burden TB areas. Few studies evaluated the safety of biolog...
Antirreumáticos/efectos adversos,
Tuberculosis/epidemiología,
Tuberculosis/inducido químicamente,
Espondiloartritis/tratamiento farmacológico,
Incidencia,
Inhibidores del Factor de Necrosis Tumoral/efectos adversos,
Productos Biológicos/efectos adversos,
Tuberculosis Latente/tratamiento farmacológico,
Inhibidores del Factor de Necrosis Tumoral/uso terapéutico,
Antirreumáticos/uso terapéutico,
Artritis Psoriásica/tratamiento farmacológico,
Espondilitis Anquilosante/tratamiento farmacológico,
Productos Biológicos/uso terapéutico,
Enfermedades Endémicas,
Estudios Retrospectivos,
Estudios de Seguimiento
Resumen La psoriasis es una enfermedad cutánea común, con prevalencia mundial entre el 0,9-8,5%. Es una condición inflamatoria crónica, inmunológicamente mediada, que lleva a hiperplasia epidérmica con gran variedad de formas clínicas. La psoriasis ostrácea es una variante hiperqueratósica infre...
Resumen Se presenta una imagen gammagráfica que muestra en forma didáctica características típicas de la artritis psoriásica....
Objetivo: O Planserv oferece cobertura à terapia biológica para as patologias de artrite reumatoide (AR), espondilite anquilosante (EA) e artrite psoriática (AP). Em agosto de 2016, 78 pacientes estavam em uso do medicamento Remicade® (infliximabe). Nessa data, o valor do Remicade® foi reduzido para...
ABSTRACT Cicatricial ectropion may be a consequence of certain systemic diseases as well as the result of drug use. Our goal here was to research the different causes of this condition as reported in the literature, including more recently suspected etiologies. A detailed PubMed literature search indicat...
A B S T R A C T Objective: The objective of this study was to establish recommendations for the reduction and discontinuation of biological disease-modifying antirheumatic drugs, with the aim of becoming a guide document for health professionals involved in the management of patients with rheumatoid ar...
Abstract Background: Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The objective of the study was to evaluate the profile of ad...
Abstract Background: To investigate the link between carbamylated low-density lipoprotein (ca-LDL), atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli's risk indices I and II (CRI I and II) and subclinic atherosclerosis in psoriatic arthritis (PsA). Methods: Thirty-ninepatients a...
Abstract Background: Nail involvement has been described as a key clinical feature for both psoriasis (PsO) and psoriatic arthritis (PsA) and is an important risk factor in PsA. Thus, early diagnosis of nail involvement may be essential for better management of PsO and PsA. Ultrasonography is considered...
